Livzon Pharmaceutical Group (1513) Price & Analysis

Compare

0 Followers

1513 Stock Chart & Stats

Day’s Range― - ―

52-Week RangeHK$23.10 - HK$34.00

Previous CloseN/A

Volume226.80K

Average Volume (3M)1.14M

Market Cap

HK$33.92B

Enterprise ValueN/A

Total Cash (Recent Filing)HK$10.90B

Total Debt (Recent Filing)¥3.77B

Price to Earnings (P/E)11.8

Beta0.62

Next Earnings

Aug 21, 2025

EPS Estimate

0.6

Next Dividend Ex-Date

Jun 13, 2025

Dividend Yield4.98%

Share Statistics

EPS (TTM)0.76

Shares Outstanding299,807,130

10 Day Avg. Volume1,225,926

30 Day Avg. Volume1,137,250

Financial Highlights & Ratios

PEG Ratio23.70

Price to Book (P/B)1.53

Price to Sales (P/S)0.00

P/FCF Ratio19.88

Enterprise Value/Market CapN/A

Enterprise Value/RevenueN/A

Enterprise Value/Gross ProfitN/A

Enterprise Value/EbitdaN/A

Forecast

1Y Price Target

HK$22.98

Price Target Upside-21.45% Downside

Rating ConsensusModerate Sell

Number of Analyst Covering0

Livzon Pharmaceutical Group News

PremiumCompany Announcements

Livzon Pharmaceutical Group Secures Shareholder Approval for Key Resolutions

9d ago

PremiumCompany Announcements

Livzon Pharmaceutical Announces Final Dividend Update for 2024

9d ago

PremiumCompany Announcements

Livzon Pharmaceutical Updates Nomination Committee Terms

16d ago

PremiumCompany Announcements

Livzon Pharmaceutical Group Announces Board Composition and Committee Memberships

16d ago

PremiumCompany Announcements

Livzon Pharmaceutical Expands with Major Vietnamese Acquisition

16d ago

PremiumCompany Announcements

Livzon Pharmaceutical Cancels Repurchased H Shares, Reduces Capital

24d ago

PremiumCompany Announcements

Livzon Pharma Gains Approval for Innovative Schizophrenia Treatment

29d ago

PremiumCompany Announcements

Livzon Pharmaceutical Group Strengthens LivzonBio with Capital Contribution

1M ago

See All HK:1513 News

See All News >

Financials

Income Statement >

Options Prices

Currently, No data available

---

Ownership Overview

―

Insiders

1.87%

Mutual Funds

― Other Institutional Investors

95.36% Public Companies and

Individual Investors

Detailed Ownership Overview >

1513 FAQ

What was Livzon Pharmaceutical Group Class H’s price range in the past 12 months?

Livzon Pharmaceutical Group Class H lowest stock price was HK$23.10 and its highest was HK$34.00 in the past 12 months.

What is Livzon Pharmaceutical Group Class H’s market cap?

Livzon Pharmaceutical Group Class H’s market cap is HK$33.92B.

When is Livzon Pharmaceutical Group Class H’s upcoming earnings report date?

Livzon Pharmaceutical Group Class H’s upcoming earnings report date is Aug 21, 2025 which is in 75 days.

How were Livzon Pharmaceutical Group Class H’s earnings last quarter?

Livzon Pharmaceutical Group Class H released its earnings results on Apr 23, 2025. The company reported HK$0.757 earnings per share for the quarter, beating the consensus estimate of HK$0.746 by HK$0.011.

Is Livzon Pharmaceutical Group Class H overvalued?

According to Wall Street analysts Livzon Pharmaceutical Group Class H’s price is currently Overvalued. Get more investment ideas with TipRanks Premium

Does Livzon Pharmaceutical Group Class H pay dividends?

Livzon Pharmaceutical Group Class H pays a Annually dividend of HK$1.169 which represents an annual dividend yield of 4.98%. See more information on Livzon Pharmaceutical Group Class H dividends here

What is Livzon Pharmaceutical Group Class H’s EPS estimate?

Livzon Pharmaceutical Group Class H’s EPS estimate is 0.6.

How many shares outstanding does Livzon Pharmaceutical Group Class H have?

Livzon Pharmaceutical Group Class H has 299,807,130 shares outstanding.

What happened to Livzon Pharmaceutical Group Class H’s price movement after its last earnings report?

Livzon Pharmaceutical Group Class H reported an EPS of HK$0.757 in its last earnings report, beating expectations of HK$0.746. Following the earnings report the stock price went up 0.752%.

Which hedge fund is a major shareholder of Livzon Pharmaceutical Group Class H?

Currently, no hedge funds are holding shares in HK:1513

Livzon Pharmaceutical Group Stock Smart Score

Neutral

Fundamentals

Return on Equity

14.56%

Trailing 12-Months

Asset Growth

-3.12%

Trailing 12-Months

Top Smart Score Stocks >

Company Description

Livzon Pharmaceutical Group Class H

Livzon Pharmaceutical Group Co., Ltd. (1513) is a leading pharmaceutical company based in China, engaged in the research, development, manufacturing, and distribution of a wide range of pharmaceutical products. The company operates in multiple sectors, including pharmaceuticals, healthcare products, and diagnostic reagents. Livzon is renowned for its core products, which comprise prescription drugs, over-the-counter (OTC) medications, and traditional Chinese medicine (TCM) products, catering to various therapeutic areas such as antibiotics, cardiovascular, gastroenterology, and endocrinology.

1513 Stock 12 Month Forecast

Average Price Target

HK$22.98

▼(-21.45%Downside)

{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"18":"HK$18","21":"HK$21","24":"HK$24","27":"HK$27","30":"HK$30"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":23.0000001618625,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">HK$23.00</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":22.9753375,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">HK$22.98</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":23.0000001618625,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">HK$23.00</span>\n  </div></div>","useHTML":true}}],"tickPositions":[18,21,24,27,30],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Mar<br/>2020","6":"Dec<br/>2020","9":"Sep<br/>2023","12":"Oct<br/>2024","25":"Oct<br/>2025"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,29.55,29.046153858604807,28.542307717209617,28.038461575814424,27.53461543441923,27.030769293024036,26.526923151628846,26.023077010233653,25.519230868838463,25.01538472744327,24.511538586048076,24.007692444652882,23.503846303257692,{"y":23.0000001618625,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,29.55,29.04425673076923,28.53851346153846,28.032770192307694,27.527026923076924,27.021283653846154,26.515540384615385,26.009797115384615,25.504053846153845,24.998310576923075,24.492567307692305,23.98682403846154,23.48108076923077,{"y":22.9753375,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,29.55,29.046153858604807,28.542307717209617,28.038461575814424,27.53461543441923,27.030769293024036,26.526923151628846,26.023077010233653,25.519230868838463,25.01538472744327,24.511538586048076,24.007692444652882,23.503846303257692,{"y":23.0000001618625,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":24.411,"date":1575158400000,"info":"<div class=\"mt2 colorgray-1\">\n          No historical consensus available\n      </div>","marker":{"enabled":true,"symbol":"circle"}},{"y":24.411,"date":1577836800000,"info":"<div class=\"mt2 colorgray-1\">\n          No historical consensus available\n      </div>","marker":{"enabled":true,"symbol":"circle"}},{"y":24.411,"date":1580515200000,"info":"<div class=\"mt2 colorgray-1\">\n          No historical consensus available\n      </div>","marker":{"enabled":true,"symbol":"circle"}},{"y":24.411,"date":1583020800000,"info":"<div class=\"mt2 colorgray-1\">\n          No historical consensus available\n      </div>","marker":{"enabled":true,"symbol":"circle"}},{"y":24.411,"date":1583020800000,"info":" <span style=\"color:#912767\" class=\"mb3 mt2 fonth8_semibold\"> Strong Sell</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 0,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#912767","enabled":true,"symbol":"circle"}},{"y":24.411,"date":1585699200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 1,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":24.411,"date":1606780800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 2,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":20.965,"date":1638316800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 2,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":19.525,"date":1661990400000,"info":" <span style=\"color:#912767\" class=\"mb3 mt2 fonth8_semibold\"> Moderate Sell</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 1,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"lineColor":"#912767","enabled":true,"symbol":"circle"}},{"y":23.436,"date":1693526400000,"info":" <span style=\"color:#912767\" class=\"mb3 mt2 fonth8_semibold\"> Strong Sell</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 0,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 3</span>\n      ","marker":{"lineColor":"#912767","enabled":true,"symbol":"circle"}},{"y":24.19,"date":1696118400000,"info":" <span style=\"color:#912767\" class=\"mb3 mt2 fonth8_semibold\"> Moderate Sell</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 1,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"lineColor":"#912767","enabled":true,"symbol":"circle"}},{"y":22.823,"date":1704067200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 2,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":29.55,"date":1727740800000,"info":" <span style=\"color:#828080\" class=\"mb3 mt2 fonth8_semibold\"> Hold</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 2,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}

Detailed Analyst Forecast >